Shares in NuVasive Inc. (NSDQ:NUVA) have risen slightly today after the medical device maker beat earnings per share expectations on Wall Street with its fourth quarter and full year 2018 earnings report. The San Diego-based company posted profits of approximately $12.2 million, or 23¢ per share, on sales of $288.3 million for the three months ended […]
NuVasive wins FDA, CE Mark for Precice internal bone transport system
NuVasive Inc. (NSDQ:NUVA) said today that it won FDA 510(k) clearance and CE Mark clearance in the European Union for its Precice bone transport system. The San Diego, Calif.-based company touted the system as the only all-internal system indicated for use in segmental bone loss treatment in the tibia and femur resulting from trauma or infection. […]
Alphatec touts stay in NuVasive patent infringement case
Alphatec (NSDQ:ATEC) said today that a U.S. District Court granted a stay in a the patent litigation between it and competitor NuVasive (NSDQ:NUVA) while the U.S. Patent and Trademark Office considers recently filed challenges from Alphatec. The Carlsbad, Calif.-based company said that the stay, which was agreed to by both companies, was granted by the U.S. District […]
Report: Smith & Nephew eyeing $3B NuVasive acquisition
Smith & Nephew (NYSE:SNN) is in discussions to pick up spine-focused medtech developer NuVasive Inc. (NSDQ:NUVA) in a deal that could be worth more than $3 billion, according to a report from the Financial Times released late last week. The companies have not officially commented on the possible acquisition. NuVasive has a market valuation of approximately $2.6 […]
Abiomed jumps on fiscal Q3 prelims, raised outlook | Wall Street Beat
Abiomed (NSDQ:ABMD) shares got a jump today from its preliminary fiscal third-quarter numbers and an improved outlook for the rest of its fiscal year. The Danvers, Mass.-based heart pump maker said it expects to post fiscal Q3 sales of roughly $200.6 million, representing a 30.3% increase over its fiscal Q3 top line. Abiomed also raised […]
Former Rotation Medical CEO Shadan joins Miach Ortho | Personnel Moves – January 3, 2019
Early stage medtech firm Miach Orthopaedics said today that it named former Rotation Medical CEO and medtech vet Martha Shadan as its new prez and chief executive officer. Shadan has held numerous leadership positions at medtech firms, including Zimmer Biomet (NYSE:ZBH), Covidien, Bristol Myers Squibb and Merck, Westborough, Mass.-based Miach said. Prior to joining Miach, Shadan […]
Ex-NuVasive COO Miles loses in noncompete battle
Former NuVasive Inc. (NSDQ:NUVA) chief operating officer Patrick Miles has lost a battle with their former employer over the enforceability of a non-compete agreement in California after a Delaware Chancery Court ruled that non-compete agreements negotiated by legal counsel may be enforced against California residents, according to a National Law Review posting. California law generally prohibits […]
NuVasive wins expanded FDA nod for Monolith corpectomy system
NuVasive (NSDQ:NUVA) said yesterday that it won expanded FDA 510(k) clearance for its Monolith corpectomy system, now cleared for use in cervical corpectomy procedures. The system is now cleared for procedures in the cervical spine, between the C3-C7 vertebral bodies, to treat diseased or damaged vertebral body caused by fractures, tumors, osteomyelitis or to support reconstruction […]
NuVasive wins FDA nod for Cohere XLIF implant components
NuVasive (NSDQ:NUVA) said today it won FDA 510(k) clearance for Cohere porous PEEK implants that are part of its Extreme Lateral Interbody Fusion surgical spinal procedures. The San Diego-based company touted that its porous PEEK technology offers both three-dimensional architecture and the radiolucent properties of PEEK, which it claims provides “increased clarity in postoperative x-rays and […]
NuVasive posts mixed bag Q3
NuVasive (NSDQ:NUVA) today released third quarter earnings that beat Wall Street expectations for revenue but missed on earnings per share consensus. The San Diego-based company posted profits of $15.9 million, or 56¢ per share, on sales of $271.3 million for the three months ended September 30, seeing profits shrink 52.5% while sales grew 9.8% compared with […]
NuVasive taps Medtronic surgical innovation prez Barry as new CEO | Personnel Moves – October 19, 2018
NuVasive (NSDQ:NUVA) said today it named Medtronic (NYSE:MDT) surgical innovations prez J. Barry as its new CEO, replacing Gregory Lucier, effective November 5. Barry will also join the company’s board of directors, where Lucier will continue to serve as board chair and aid in transition efforts, the San Diego-based company said. NuVasive also said that it promoted current strategy, […]
- 1
- 2
- 3
- …
- 22
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube